Abstracts Archive - Page 2071 of 2607 - ACR Meeting Abstracts

Abstract Number: 2434 • 2014 ACR/ARHP Annual Meeting
Gait Instability in the Elderly: A New Dedicated out-Patients Consultation
Vincent Goeb¹, Bernard Auvinet² and Claude Touzard³, ¹Rhumatology Department, University Hospital, AMIENS, France, ²Rheumatology Unit, Polyclinic, LAVAL, France, ³Gerontology Unit, Hospital of Laval, LAVAL, France
Background/Purpose Gait instability which represents a common but non-specific complaint, mainly in the elderly, is of major interest in PubMed (6038 references). Gait Instability can…
Abstract Number: 2435 • 2014 ACR/ARHP Annual Meeting
‘It’s like the Worst Toothache You’ve Ever Had’ – How Persons with Rheumatoid Arthritis Describe and Manage Pain in Daily Life
Maria Bergström¹, Inger Ahlstrand², Ingrid Thyberg³, Torbjörn Falkmer⁴, Björn Börsbo⁵ and Mathilda Björk⁶, ¹School of Health Sciences, Jönköping University, Jönköping, Sweden, ²School of Health Sciences Jönköping University, Jönköping, Sweden, ³Rheumatology, Linköping University Hospital, Linkoping, Sweden, ⁴School of Occupational Therapy and Social Work, CHIRI, Curtin University, Perth, WA, Australia, Perth, Australia, ⁵Rehabilitation Medicine, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden, ⁶Rehabilitation Center and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
Background/Purpose: Although it is reported that biological treatment has a positive effect on Rheumatoid arthritis (RA), pain intensity is still moderate to high in the…
Abstract Number: 2436 • 2014 ACR/ARHP Annual Meeting
Analytical and Clinical Evaluation of an Immunoassay for Estimating Immunogenicity of Infliximab and Etanercept in Indian Population
Canna Ghia¹, Shashank Akerkar², Shailaja Sabnis³, Rao RK Uppuluri⁴ and Gautam Rambhad⁵, ¹Medical, Medical Advisor, Pfizer Limited, India, Mumbai, India, ²Rheumatology, Mumbai Arthritis Clinic and Research Centre, Mumbai, India, ³Rheumatology, Sneh Nursing Home,, mumbai, India, ⁴Rheumatology, Sri Deepti Rheumatology Centre, Hyderabad, India, ⁵Medical, Associate Director Medical Services, Pfizer Limited, India, Mumbai, India
Background/Purpose Biologic anti-TNFs in India have improved the patient management. Significant proportions of patients lose response over time or do not respond. Possible explanations are…
Abstract Number: 2437 • 2014 ACR/ARHP Annual Meeting
Why Doesn’t Participation in Activity Increase Following Hip or Knee Replacement?
Aileen Davis¹, Viji Venkataramanan¹, Jessica Bytautas², Rose Wong¹, Lisa Carlesso¹, Anthony Perruccio³ and Fiona Webster², ¹Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ²Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada, ³Toronto Western Hospital, University Health Network, Toronto, ON, Canada
Background/Purpose Activity is critical for healthy aging. Our prior work demonstrated that despite improved pain and function, people did not increase their participation in activity…
Abstract Number: 2438 • 2014 ACR/ARHP Annual Meeting
A Multi-Centre Survey of Tolerability Problems for Patients on Regular Methotrexate
David Walker¹, Emmanuel George², Sarah Gibson³, Una Martin⁴, Hilary Wrightson⁵, Peta S. Heslop⁶, Peter Prowse⁷, Matthew Kalinowski⁷, Adewale O. Adebajo⁸, David Marshall⁹, Michael Reed¹⁰ and Sandra M. Robinson⁶, ¹Dept of Rheumatology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom, ²Rheumatology, Wirral University Teaching Hospital NHS Foundation Trust, The Wirral, United Kingdom, ³Rheumatology, WIRRAL UNIVERSITY TEACHING HOSPITAL NHS FOUNDATION TRUST, The Wirral, United Kingdom, ⁴Rheumatology, Waterford Regional Hospital, Waterford, United Kingdom, ⁵Rheumatology, Northumbria Healthcare NHS Foundation Trust, North Shields, United Kingdom, ⁶R&D, North Tyneside General Hospital, North Shields, United Kingdom, ⁷Rheumatology, Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom, ⁸Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom, ⁹Department of Rheumatology, Inverclyde Royal Hospital, Greenock, United Kingdom, ¹⁰Rheumatology, Inverclyde Royal Hospital, Greenock, United Kingdom
Background/Purpose Methotrexate has become the core DMARD for the treatment of Rheumatoid Arthritis. It has also found utility in treating other forms of inflammatory arthritis…
Abstract Number: 2439 • 2014 ACR/ARHP Annual Meeting
Knee Joint Pathology in Patients with Rheumatoid Arthritis and Osteoarthritis Using a Validated Ultrasound Scoring System: A Cross Sectional Study
Karen Ellegaard¹, Marius Henriksen², Birgit Falk Riecke³, Søren Just⁴, Jakob Espesen⁵, Mohammed Yusuf Naderi⁶ and Henning Bliddal³, ¹Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark, ²Department of Rheumatology, The Parker Institute, Copenhagen University Hospital at Frederiksberg, Copenhagen F, Denmark, ³The Parker Institute, Copenhagen, Denmark, ⁴Department of Rheumatology, Svenborg Sygehus, Svendbotg, Denmark, ⁵Odense Universitetshospital, Odense, Denmark, ⁶Department of Rheumatology, Esbjerg Sygehus, Esbjerg, Denmark
Background/Purpose Ultrasound (US) signs of inflammation in joints are synovial hypertrophy, effusion, and Doppler activity (increased perfusion), which have been demonstrated in both osteoarthritis (OA)…
Abstract Number: 2440 • 2014 ACR/ARHP Annual Meeting
Factors Influencing Health Related Quality of Life (HR-QOL) for Korean Patients with Rheumatoid Arthritis
SeungIn Paek¹, Kyeong Yae Sohng² and Sung-Hwan Park³, ¹Center for Rheumatic disease, ST Mary's Hospital, Seoul, South Korea, ²College of Nursing, The Catholic Univ of Korea, Seoul, South Korea, ³Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
Background/Purpose The purpose of this study was to identify factors influencing the Health-related quality of life (HR-QOL) for Korean patients with rheumatoid arthritis and factors…
Abstract Number: 2441 • 2014 ACR/ARHP Annual Meeting
Prevalence and Determinants of Treatment Adherence Among Patients with Rheumatoid Arthritis
Maria Celeste Orozco¹, Maria Florencia Marengo², Christian A. Waimann², Ana Inés Marcos³, Amelia Granel³, Sofia Velez⁴, Federico Zazzetti⁵, Juan C. Barreira⁶, Paula Kohan⁷, Oscar L. Rillo⁸, María Victoria Collado⁹, Graciela Gómez¹⁰, Ricardo V. Juárez¹¹, Veronica Lencina¹², Andrea D'Orazio¹³, Gustavo Rodriguez Gil¹³, Mariana Salcedo¹⁴ and Gustavo Citera¹⁵, ¹Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³Rheumatology, Hospital San Roque de Gonnet, La Plata, La Plata, Argentina, ⁴Rheumatology, Hospital Britanico, Buenos Aires, Argentina, ⁵Hospital Britanico, Buenos Aires, Argentina, ⁶Rheumatology, British Hospital, Buenos Aires, Argentina, ⁷rheumatology, Hospital Gral. de agudos Dr. E. Tornú, Buenos Aires, Argentina, ⁸Rheumatology Unit, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, ⁹Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, ¹⁰Diaz Colodrero 2537 8° A, Insituto de Investigaciones Medicas de la UBA, Capital Federal, Argentina, ¹¹Rheumatology Section, Hospital Señor del Milagro, Salta, Argentina, ¹²Rheumatology section, Hospital Señor del Milagro, Salta, Argentina, ¹³rheumatology, Hospital Municipal de agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina, ¹⁴Consultorio Privado, San Nicolás, Argentina, ¹⁵Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose : Treatment adherence is a crucial part of successfully managing rheumatic diseases such as Rheumatoid Arthritis (RA). Low adherence to treatment has been related…
Abstract Number: 2442 • 2014 ACR/ARHP Annual Meeting
Aligning Ethics with Digital Health Technologies and Shared Decision-Making: Interview Accounts of Patients and Clinicians
Anne F. Townsend^1,2,3,4, Paul Adam⁵, Jenny Leese⁶, Linda C. Li^6,7, Michael McDonald², Sheila Kerr⁸, Gordon Whitehead⁸ and Catherine Backman^6,9, ¹Qualitative Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, ²Maurice Young Centre for Applied Ethics, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, ³Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, ⁴University of British Columbia, Vancouver, BC, Canada, ⁵Mary Pack Arthritis Centre, Vancouver, BC, Canada, ⁶Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁷Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ⁸Arthritis Patient Advisory Board, Richmond, BC, Canada, ⁹Department of Occupational Science & Occupational Therapy, University of British Columbia, Vancouver, BC, Canada
Background/Purpose Medical ethics evolves as health care develops. Digital health technologies are transforming health care delivery and patient and clinician relationships. Ethical approaches are shifting…
Abstract Number: 2443 • 2014 ACR/ARHP Annual Meeting
A New Meta-Analysis on Safety of Ketoprofen Vs Ibuprofen and Diclofenac: Risk and Benefit of Nsaids Beyond Efficacy Meta-Analysis
P. Sarzi-Puttini¹, F. Atzeni¹, Luigi Lanata², Alessandra Monguzzi² and Michela Bagnasco², ¹Rheumatology Unit, L. Sacco University Hospital of Milan, Milan, Italy, ²Medical Department, Dompé SpA, Milan, Italy
Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for management of mild-to-moderate pain, chronic inflammatory and degenerative joint diseases. Among NSAIDs, ketoprofen, ibuprofen and diclofenac…
Abstract Number: 2444 • 2014 ACR/ARHP Annual Meeting
Pharmacist-Developed Letters May Enhance Success in Obtaining Insurer Approval for Off-Label Use of Biologics
Jessica F. Farrell^1,2,3, Lee S. Shapiro^1,2,4, Joel M. Kremer⁵ and Aixa Toledo-Garcia⁶, ¹Steffens Scleroderma Center, Saratoga Springs, NY, ²The Center for Rheumatology, Albany, NY, ³Pharmacy Practice, Albany College of Pharmacy & Health Sciences, Albany, NY, ⁴Albany Medical College, Albany, NY, ⁵Medicine, Albany Medical College and the Center for Rheumatology, Albany, NY, ⁶Rheumatology, The Center for Rheumatology, Albany, NY
Background/Purpose A growing number of publications suggest that biological DMARDs, predominantly approved for RA, can be efficacious treatment options for several rare rheumatic diseases. These potentially…
Abstract Number: 2445 • 2014 ACR/ARHP Annual Meeting
A Distinct Profile of Circulating Microparticles Is Associated with Disease Features in Rheumatoid Arthritis Patients and Impairs Endothelial Functionality in Vitro
Javier Rodríguez-Carrio¹, Mercedes Alperi-López², Patricia López¹, Sara Alonso-Castro², Santiago Rubén Carro-Esteban¹, Javier Ballina-García² and Ana Suárez¹, ¹Area of Immunology, Department of Functional Biology, University of Oviedo, Oviedo, Spain, ²Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
Background/Purpose Cell-derived microparticles (MPs) could be considered biomarkers of cell damage and activation and they are thought to have a role in cardiovascular (CV) and inflammatory…
Abstract Number: 2446 • 2014 ACR/ARHP Annual Meeting
DNA Methylation Profiles That Distinguish Rheumatoid Arthritis from Osteoarthritis in Fibroblast-like Synoviocytes Can be Detected in Immune Cells from Peripheral Blood
Brooke Rhead¹, Calliope Holingue², Michael Cole², Xiaorong Shao², Hong L. Quach³, Diana Quach³, Lisa F. Barcellos³ and Lindsey A. Criswell⁴, ¹Genetic Epidemiology and Genomics Laboratory, Division of Epidemiology, University of California, Berkeley, Berkeley, CA, ²Genetic Epidemiology and Genomics Lab, Division of Epidemiology, University of California, Berkeley, Berkeley, CA, ³Epidemiology, University of California, Berkeley, Berkeley, CA, ⁴Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease with potential to cause substantial disability, primarily due to the erosive and deforming process in joints.…
Abstract Number: 2447 • 2014 ACR/ARHP Annual Meeting
The Role of TET3-Mediated DNA Demethylation By Pro-Inflammatory Cytokines in Rheumatoid Arthritis
Kazuhisa Nakano¹, Kunihiro Yamaoka¹, Akira Kurozumi², Akio Kawabe², Kaoru Yamagata² and Yoshiya Tanaka³, ¹The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, ²The first department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, ³University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
Background/Purpose In the pathogenesis of Rheumatoid arthritis (RA) RA fibroblast-like synoviocytes (RA FLS) exhibit a unique aggressive phenotype that contributes to the cytokine milieu and…
Abstract Number: 2448 • 2014 ACR/ARHP Annual Meeting
DNA Methylation Analysis of Lymph Node Stromal Cells of Rheumatoid Arthritis Patients
Emmanuel Karouzakis¹, Caroline Ospelt¹, Janine Hähnlein², Renate E. Gay³, Paul Peter Tak⁴, Danielle Marie Gerlag⁵, Michel Neidhart¹, Steffen Gay¹ and Lisa G.M. van Baarsen², ¹Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, ²Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, ³Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland, ⁴University of Cambridge,Cambridge and GlaxoSmithKline, Stevenage, United Kingdom, ⁵GSK,Clinical Unit Cambridge,R&D Projects Clinical Platforms & Sciences, Cambridge, United Kingdom
Background/Purpose Lymph node stromal cells (LNSC) build the scaffold that enables migration and interaction of lymphocytes in the lymph node. More recently, it has been…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].